NCT05565417 2025-10-16Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasImmunitas TherapeuticsPhase 1/2 Active not recruiting67 enrolled
NCT03976856 2021-03-03Safety and Efficacy of Genolimzumab (GB226) in Combination With FruquintinibGenor Biopharma Co., Ltd.Phase 1 Unknown42 enrolled